Statements Author contributions JZ: Writing original draft
BPC-157 is the one component that does land in range, at 400 mcg against a derived position of 250-500 mcg daily but GLOWs frequency falls to 5x and then 2-3x weekly, where injured tissue is dosed once daily
Interest in BPC-157 continues to grow across peptide science as researchers investigate its behaviour within experimental models involving cellular signalling, extracellular matrix dynamics, angiogenesis and musculoskeletal biology
J Allergy Clin Immunol 120 : S94S138 Wenzel SE, Fahy JV, Irvin C, Peters SP, Spector S, Szefler SJ, for the American Thoracic Society Workshop 2000 Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions
Laboratory research examines BPC-157s influence on fibroblast behavior and structural protein organization